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ORIGINAL  ARTICLE
Variations in the Clinical Management
of Multibacillary Leprosy Patients
in Selected Hospitals in Metro Manila
Veincent Christian F. Pepito,1 Arianna Maever L. Amit,1 Rae Erica D. Samontina,1 
Sarah Jane A. Abdon,1 David Norman L. Fuentes1 and Ofelia P. Saniel2
1College of Public Health, University of the Philippines Manila
2Department of Epidemiology and Biostatistics, College of Public Health, University of the Philippines Manila
ABSTRACT
Introduction. This paper documents the variations in the diagnosis and management of multibacillary leprosy 
patients in three of the biggest case-holding hospitals in Metro Manila. Furthermore, we aimed to discuss the 
implications of these variations on the country’s leprosy control and elimination program.
Methods. Focus group discussions (FGD) were conducted with 23 health professionals composed of doctors and 
nurses with at least a year of experience in managing leprosy patients. The topics included procedures on patient 
diagnosis and management such as treatment duration, patient follow-up and definitions of treatment completion 
and default. The FGD participants provided suggestions to improve treatment compliance of patients. Their 
responses were compared with World Health Organization (WHO) standards and/or the 2002 DOH Manual of 
Operating Procedures (MOP) for leprosy. Transcripts of the recordings of the FGDs were prepared and thematic 
analysis was then performed.
Results. There were variations in the hospitals’ procedures to diagnose leprosy, in treatment duration, and in patient 
follow-up. Definitions for treatment completion and default differed not just between hospitals but also with the 
WHO guidelines and the 2002 MOP. Hospitals extended treatment up to 24 or even 36 months, despite the 12 
months stipulated in the MOP. Two hospitals required slit skin smear and skin biopsy in diagnosis, despite the MOP 
and WHO provisions that these were not mandatory. One hospital defined default as three consecutive months 
without treatment, which was different from the MOP and WHO standards and from the other hospitals. 
Conclusion. Given the variations in patient management, we recommended that effectiveness of the standard 
treatment relative to other regimens being practiced by specialists be evaluated.
Key Words: Multibacillary Leprosy, Multiple Drug Therapy, Patient Management
INTROduCTION
Leprosy or Hansen’s disease is a chronic infectious 
illness that affects the nerves and manifests as hypoaesthetic 
macules, papules, and lesions. The World Health 
Organization (WHO) classifies it into paucibacillary (PB), 
when there are five or less hypopigmented skin lesions, and 
multibacillary (MB) when there are more than five of these 
skin lesions with invasion of the nasal mucosa.1 Patients 
with MB leprosy are treated with rifampicin, clofazimine, 
and dapsone for 12 months. Termed collectively as Multiple 
Drug Therapy (MDT), these medications are given monthly 
to patients in blister packs.1,2
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RESuLTS
Three nurses from Hospital A, five dermatology 
residents from Hospital B, and 14 dermatology residents and 
one nursing assistant from Hospital C participated in three 
separate FGDs.
The participating hospitals are three of the largest 
leprosy case-holders in the entire National Capital Region. 
Hospital A, on average, treats 40 leprosy patients, Hospital 
B treats 64, while Hospital C treats around 100 patients each 
year. All three health institutions are government-owned but 
only Hospitals A and C are DOH-retained.a Meanwhile, 
only Hospitals B and C are Philippine Dermatological 
Society (PDS) affiliated training hospitals for resident 
dermatologists. 
The following paragraphs describe the usual procedures 
performed by health workers from the selected hospitals in 
managing leprosy patients. A summary of how the three 
hospitals manage their patients are shown in Table 1.
Leprosy Diagnosis 
The 2002 NLCP MOP states that diagnosis of leprosy 
is made on the basis of clinical signs and symptoms, 
especially when there is history of contact with a positive 
case. The manual further emphasizes that rarely is there a 
need to do laboratory examination and other investigations 
to confirm a diagnosis. Slit-skin smear (SSS) examination 
is an optional diagnostic procedure that is performed when 
clinical diagnosis is doubtful. The main objective of the SSS 
is to ensure correct classification of a leprosy case as well as to 
confirm diagnosis. This is important so that the patient will 
be appropriately managed.6
Nurses from Hospital A suspect MB leprosy in a patient 
who has the characteristic lesions, infiltrations, deformities 
and nose collapse, among other features of the disease. When 
a suspected leprosy patient comes in for check-up, nurses ask 
the patient to put on a mask; this is to minimize the risk of 
transmitting the disease to other persons. Next, they assess 
the patient for numbness, lesions, and deformities. To confirm 
that the disease is indeed leprosy, they instruct the patient to 
undergo SSS examination and complete blood count (CBC) 
as part of the hospital’s standard operating procedures (SOPs). 
Skin biopsy is rarely performed; however, it is only done when 
the initial SSS result is negative. SSS, CBC, skin biopsy and 
other laboratory tests relevant to the diagnosis and clinical 
management of leprosy are free of charge in Hospital A.
Resident doctors from Hospital B suspect MB leprosy 
in a patient who presents with hypoaesthetic plaques and 
papules. After noting patient history, they test for sensation 
through neurologic physical exams, such as monofilament test. 
When lesions are found to be hypoaesthetic, they perform 
SSS and skin biopsy as part of the protocol in Hospital B for 
In the Philippines, the prevalence of leprosy has dropped 
from 7.2 per 10,000 population in 1986 to 0.31 cases per 
10,000 population by the end of 2010 and therefore has 
been eliminated as a public health problem.3,4 However, 
since pockets of cases still persist, eradication of the disease 
remains to be a challenge for the Department of Health 
(DOH). As of 2014, 90% of the 2,771 reported leprosy 
patients in the country are MB. More than a fifth of these 
patients consult treatment facilities in Metro Manila.5
The Philippine National Leprosy Control Program 
developed a Manual of Procedures (MOP) adapted from 
WHO to standardize diagnosis and management of leprosy 
patients in the country.6 We hypothesized that there is 
non-compliance with the standard procedures among 
hospitals. Variations in patient management suggest the 
need to re-evaluate its effectiveness.
This paper aims to qualitatively document differences 
in diagnostic procedures, counselling, treatment initiation 
and monitoring of treatment compliance among three of the 
largest leprosy case-holding institutions in Metro Manila. 
In addition, this paper identifies notable variations in the 
definitions of treatment completion and default. Lastly, it 
offers some suggestions on how to improve leprosy control 
and treatment compliance, which will hopefully enhance 
government efforts towards the eradication of leprosy in 
the country.
METHOdS
Health professionals with at least one year of experience 
in managing MB leprosy patients from selected hospitals 
in Metro Manila were invited to participate in focus group 
discussions (FGDs) conducted between February and June 
2015. They were asked to share their usual procedures in 
managing leprosy patients. Specifically, they were asked 
regarding leprosy diagnosis, treatment duration, patient 
follow-up, and definitions of treatment completion and 
treatment default. Lastly, they were encouraged to provide 
suggestions to improve treatment compliance of leprosy 
patients. The topic guide used in the FGD is attached as a 
technical appendix in this paper.
The ‘usual practices’ of the health workers were 
compared with the 2002 National Leprosy Control Program 
(NLCP) MOP6 and/or Eighth Report of the WHO Expert 
Committee on Leprosy.7 At the time of the conduct of the 
study, these two documents contained the latest local and 
international standard guidelines for management of leprosy 
patients. The contents of the said documents, as well as the 
responses of medical personnel to the FGD questions, were 
organized according to themes and sub-themes. Thematic 
analysis was performed afterwards using QSR NVivo 
version 10 (QSR International, Melbourne, Australia).
Certificates of approval/clearance were obtained from 
the Ethics Review Committees of the participating hospitals 
and the institution prior to the conduct of the study.
a  DOH retained hospitals refer to all hospitals under the management 
and operation of DOH Center for Health Development.
VOL. 52 NO. 3 2018 ACTA MEDICA PHILIPPINA 269
Variations in the Management of Leprosy Patients
all suspected leprosy patients. As a last and crucial step, they 
do patient work-up to help decide if a patient should start 
treatment immediately.
Before 2013, only skin biopsy was part of Hospital B’s 
SOPs in diagnosing leprosy patients. It was only later that 
SSS was included, after Hospital B doctors acknowledged 
its prognostic value. At present, specimen collection and 
processing are both done, without charge, in the hospital 
laboratory. However, reading and interpretation of test results 
are done outside the hospital for a fee. Doctors could waive 
this payment if the patient is indigent. Nevertheless, getting 
the smear read/interpreted outside the hospital may be 
inconvenient and costly for some patients so they opt not to 
have their SSS results read.
Dermatology residents from Hospital C suspect 
MB leprosy in a patient with erythematous patches and 
plaques. They consider the case as severe leprosy when a 
person presents with leonine facies and contracture of the 
extremities. Upon presentation, the doctors take the patient 
history. Afterwards, they perform physical and neurological 
examinations, SSS and skin biopsy. Results for the SSS are 
often available in the afternoon of the same day if the test 
was done in the morning; if not, the results are available 
the day after. Meanwhile it takes two weeks for skin biopsy 
results to be released.
CBC, SSS, skin biopsy, urinalysis, and liver and kidney 
function tests are performed for free in Hospital C. However, 
patients are required to pay for tests such as chest X-ray and 
glucose-6-phosphate dehydrogenase (G6PD) test.
Treatment Initiation
The 2002 MOP stipulates that treatment should start as 
soon as leprosy is confirmed in a patient.6
In Hospital A, nurses start treatment on the same day of 
diagnosis. However, some patients leave the hospital instead 
of waiting for their test results. This contributes to delay in 
treatment initiation.
Initiation of treatment in Hospital B is done on a case-
to-case basis. Doctors start treatment right away in patients 
who manifest severe forms of leprosy such as madarosis or 
thinning of the eyebrows, and enlargement of ear lobules, 
even in the absence of confirmatory test results (i.e., SSS 
and skin biopsy). Unlike in Hospital A, Hospital B requires 
G6PD test to be done prior to starting the treatment. The 
doctors explained that G6PD assay is necessary to determine 
whether or not hemolytic anemia will occur when the patient 
takes in dapsone. They believe that having G6PD test will not 
cause a delay in initiation of treatment.
Similarly, doctors from Hospital C start treatment 
immediately only when the SSS result is positive. If it is found 
negative however, skin biopsy is done and a positive test result 
would indicate that treatment be started immediately. In 
these cases, treatment is said to start two weeks after the first 
consultation. G6PD test is a required procedure for leprosy 
patients in Hospital C as well. 
Counselling
The WHO Expert Committee’s report emphasizes the 
importance of counselling in addressing stigma of leprosy.7 
The 2002 MOP, however, does not contain standards on 
the conduct of counselling for leprosy patients. Therefore, 
hospitals have different ways of counselling their patients as 
discussed in the succeeding paragraphs.
After diagnosis is confirmed, medical personnel of 
Hospital A ask patients regarding their knowledge of leprosy. 
Discussions about the disease, its manifestations, and its 
mode of transmission follow. In explaining the disease to 
the patient, health workers avoid using the term “ketong” – 
the local name for leprosy – due to the stigma attached to it. 
Instead, they use the terms “Hansen’s disease” or “leprosy”. 
If relatives of patients are present, they are also invited to 
join the counselling session to encourage them to take part 
in the patient’s treatment compliance and recovery. Two 
examples of how a nurse and a resident conduct counselling 
are provided below:
“I tell the patients that the disease is easy to cure. 
Just take the medications religiously. And after taking 
the medications for seven days, the bacteria are no longer 
as infective as before so as to spread the disease to those 
who live with you. But I also tell them the truth that 
‘before this check-up, everyone has already been exposed 
to you. There is a possibility that someone got infected, 
depending on his/her resistance. After that, I reiterate 
that after seven days, they are no longer infectious. This 
is important as their spouses are afraid of them.”
- Nurse from Hospital A
“With regards to stigma, I personally avoid using 
the word ‘ketong’. When I talk to the patient, I tell them 
‘you have Hansen’s or leprosy’. If they hear the term 
‘ketong’, their reaction is like, ‘Ketong? Where did I get 
that?’. If you say it’s Hansen’s, it is like a kinder, gentler 
way of telling them what their illness is. And then if 
we explain that this is what is happening to you, this is 
your condition, they are more receptive of the diagnosis.”
- Dermatology resident from Hospital B
Meanwhile, resident doctors from Hospital C start 
counselling once SSS result is positive. In their sessions, 
they focus on the prognosis, as well as the consequences and 
implications of having the disease. In the hospital, counselling 
is said to be a long process that requires an entire day for new 
patients. However, for those who visit regularly, the process 
is relatively shorter. Counselling in this health institution 
usually begins with an explanation of the disease, its modes 
of transmission, and more importantly, its ability to infect 
other people in the household. Aside from introducing the 
patient to the disease, emphasis is placed on the necessity of 
treatment compliance and follow-up examinations once there 
are observable physiologic changes.
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“In counselling, we also stress the importance 
of compliance. They should also know the possible 
reactions to the drug because in leprosy, reactions are 
common because their immune system changes. (The 
message is that) even though they will have reactions, 
they should not stop taking the drug. Basically, we 
explain the treatment duration because it is for a year, 
for example, for multibacillary. So, we really explain 
that it is a long-term treatment, so you should follow-
up with us. Because one of their problems is that 
when they experience contractures, they will no longer 
return for treatment. We always emphasize ‘once you 
experience anything unusual, please come back and 
have yourself checked’.”
- Dermatology resident from Hospital C
As part of counselling, flyers and pamphlets are given 
to leprosy patients in Hospitals A and B. In addition, the 
staff in the two hospitals supervise sessions provided by their 
respective Hansen’s Clubs which allows: 1) counselling of 
several patients all at once; 2) supplementation of the usual 
doctor-patient counselling; and 3) interactions of patients 
with each other to share their experiences of living with 
the disease. 
Hospital C has its own active leprosy support group that 
facilitates activities such as spiritual discussions, meetings and 
livelihood programs. However, its direct role in counselling 
was not explored during the FGDs.
Patient Monitoring
The 2002 NLCP MOP contains provisions for 
monitoring patients with special needs, as well as guidelines 
for monitoring clinical progress. For convenience and 
economy, patients who live far from the hospital are given 
more than a month’s supply of medicines so that they need 
not come back often for their drugs:6
“…They should be given sufficient supply of the 
drugs to cover the period of absence. It is acceptable to 
give full course of treatment to these patients but they 
should be advised to report to the nearest rural health 
unit if they have complications.”
- 2002 MOP p. 15
The MOP also stipulates that concerned health workers 
should note the following every time a patient returns for 
treatment:6
“Changes in the character of the lesion, pain in 
the eyes, changes in color of sclera and conjunctiva, 
new disabilities, or progression of previous disabilities, 
and nerve damage in the form of nerve pain, painless 
wounds or blisters, and difficulty in performing simple 
tasks like holding a pen, buttoning a shirt, or signs of any 
weakness or loss of prehensile skill.”
- 2002 MOP p. 17
Nurses from Hospital A relate that MDT blister packs 
should be given monthly. A nurse recounted that she sends 
Short Messaging Service (SMS) messages to patients to 
remind them to come to the clinic to get their monthly MDT 
and for their regular checkup. Although this technique works 
to some extent, some patients do not give their true mobile 
numbers and therefore, cannot be contacted. Hospital A 
medical personnel also reported that some patients lie about 
their addresses so that they would not be located during 
contact tracing. The nurses attribute these infractions among 
the patients could be due to stigma attached to the disease. 
“Like yesterday a neighbor of a patient approached 
me. The patient was already on treatment for eight 
months but eventually defaulted. Then the neighbor 
passed by the clinic. The neighbor asked if it was possible 
to ask for medications for the patient. I said, ‘No, because 
the patient needs to be checked-up again’. The drug is for 
free, the patient just needs to come back.”
- Nurse from Hospital A
There are cases in which the patient himself/herself 
requests for additional blister packs, presumably to minimize 
cost of transportation and long commute time. The nurses 
comply under reasonable circumstances (e.g. They gave 
12 doses to an overseas contract worker assigned in Saudi 
Arabia); but they emphasize to patients that when lesions 
appear, they should come back to the hospital immediately to 
be checked by a health professional. 
Doctors from Hospital B mentioned that it is ideal for 
patients to get the drugs monthly. However, they give leeway 
to patients who live far from the hospital or to those who live 
in areas where the health center does not have regular supplies 
of MDT blister packs. Nevertheless, they emphasized that 
patients who experience lepra reactions are asked to return 
every two weeks so that their motor-sensory functions can be 
monitored closely. Otherwise, they are expected to come only 
every 28 days. No standard protocols in the way patients are 
monitored and reminded for follow-up visits were mentioned 
during the FGD.
Resident doctors from Hospital C also allow some 
flexibility with patients who live far from the hospital and 
those who are indigent. However, only a maximum of three 
MDT blister packs, enough for three months, are provided. 
Exceptions to this policy, such as giving more than three 
blister packs to patients, are only done upon approval by 
the consultants. 
Hospital C doctors check for lepra reactions, joint pains, 
and new lesions among patients who come for follow-up. 
When a patient is positive for lepra reactions, they ask him/
her to come back to the hospital every two weeks for close 
monitoring. Otherwise, they perform physical examination 
on the patient, especially the hands and feet, after which a 
nursing assistant gives him/her the MDT blister packs. They 
do not release a patient from treatment if he/she has had little 
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change in his/her bacterial index from baseline after at least 
three months from completing treatment. The procedures for 
monitoring after this time period depends on the judgment 
of the consultant. Mechanisms on how patients are reminded 
for follow-up were also not mentioned during the FGDs.
Treatment Completion
The 2002 MOP defines treatment completion as 
having taken 12 MDT blister packs within 18 months for 
multibacillary cases. The manual further specifies that lesions 
may still appear even after treatment completion but these 
lesions will eventually resolve; thus, extension of treatment 
period is highly discouraged.6
Nurses from Hospital A classify their patients who have 
completed treatment into two: those who are ‘released from 
treatment’ and those who ‘completed treatment’. According 
to them, a patient who is ‘released from treatment’ is a patient 
who has completed 12 MDT doses, is evaluated clinically, 
and is released from treatment by a doctor. On the contrary, 
a patient who ‘completed treatment’ is a patient who finished 
the prescribed number of MDT doses but did not return to 
the clinic for final evaluation. 
There are patients in Hospital A and B whose treatment 
were extended up to 18 or even 24 months.
“For example, the patient has finished 12 blister 
packs and he/she underwent slit skin smear. On the basis 
of MI (morphological index) or BI (bacterial index), 
it was seen in the bacterial index that there is still 1% 
alive (bacteria). (On this basis), the doctor will extend 
(the treatment) to 6 (more) months. Then after 6 months, 
if there are still viable bacteria detected, the bacterial 
index is still positive, (treatment will again be extended 
for another) 6 months, until 2 years. (After this, we are 
more) certain that the patient will be well by then.” 
- Nurse from Hospital A
“We really do not follow the (WHO guidelines) 
very strictly. And as of this moment, I think the WHO 
already knows the stand of leprologists of the PDS (which 
is) once you are diagnosed with lepromatous leprosy, 
you should have 24 months of treatment, because if you 
complete 24 months of treatment, the risk of relapse is 
very low compared to those who only had 12 months of 
treatment. Once you give the reason or justify why you 
extended more than 12 months, it is alright with the 
WHO to release additional medications.”
- Resident doctor from Hospital B
“The most common reasons why we extend 
treatment beyond 12 months are that patients did not 
have the desired amount of reduction in bacilli count at 
the end of 12 months, or that they still have clinically-
active lesions, or they are experiencing reactions.”
- Resident doctor from Hospital B
“Because there are also patients whom we treat as 
‘persisters.’ The term ‘persisters’ means that even after 
two years of continuous MDT, these patients are still 
positive in slit skin or skin biopsy. From experience, 
I have a patient who was diagnosed in 2008 with 
Hansen’s lepromatous. (From) 2008 to 2010, she had 
MDT for two years. After two years of MDT, we 
repeated the tests to monitor her response to treatment; 
we performed slit skin and skin biopsy then we 
found out that there are still bacteria present. So, she 
continued treatment until 2012 when she was lost to 
follow up in 2012. Then she came back last year, around 
April, and then I repeated all the tests and still, bacteria 
were present.”
- Resident doctor from Hospital B
Resident doctors from Hospital C reported that they 
make a distinction between ‘released from treatment’ and 
‘completed treatment’, utilizing similar definitions with those 
provided by Hospital A nurses. 
In Hospital A, nurses perform SSS at least twice: once 
at the start of treatment and a year later before the patient 
is released from treatment. SSS may be performed between 
these time periods as judged necessary by the doctor. 
Hospital B medical personnel perform SSS and skin biopsy 
to diagnose a patient. They then repeat every 12 months until 
the patient is released from treatment. Lastly, Hospital C 
residents perform SSS at the start of treatment and every six 
months thereafter until the patient is declared by the doctors 
to be done with the treatment. After 12 months, doctors 
check if the bacterial index is zero. If it is still positive but 
not exceeding 4+, treatment may be extended for up to six 
months. If it is at least 4+, treatment would be extended for 
another 12 months. They have recounted that some patients 
were treated for 36 months because SSS results contained 
viable bacteria even after 24 months of treatment.
Treatment Default
The 2002 MOP describes a defaulter as “a patient who 
has started treatment and who has not collected MDT drugs 
for six consecutive months”6 while current WHO definitions 
refer to a defaulter as “an individual who fails to complete 
treatment within the maximum allowed time-frame.” Thus, 
an MB leprosy patient who misses six months of treatment is 
considered as a defaulter.7
Nurses from Hospital A said that they continue to use the 
definition of default as indicated in the 2002 NLCP MOP, 
despite getting a new report containing new definitions: 
“We continue treating it as it is, but there’s 
something in the manual right? In the manual, missing 
two months is already considered a default. Usually, it is 
two or three months. But the doctor said, just continue… 
(treating as if he/she did not default).”
- Nurse from Hospital A
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Furthermore, medical personnel from Hospital A 
confirmed that they currently have no definition of default 
for those who extend treatment.
Doctors from Hospital B adhere to the current WHO 
guidelines and emphasize that the six-month leeway may not 
be consecutive. They also apply these definitions to patients 
who have their treatment extended. This means that patients 
who are assigned to be treated for 18 months and 24 months 
have a maximum of 24 and 30 months, respectively, to 
complete the treatment. 
Resident doctors from Hospital C said that they have 
more stringent criteria for default as suggested by their 
consultants. They said that if a patient does not come back for 
three consecutive months, the patient is labeled a defaulter. 
This definition also applies to patients whose treatment 
duration is extended.
Recommendations by Health Workers
This section presents recommendations suggested 
by participating health workers to improve treatment 
compliance of patients.
Establishment of Health Centers and Making 
Treatment More Available 
Health care providers mentioned that their patients 
experienced shortages in medicines back in their places of 
residence, necessitating that they travel to Manila. The health 
professionals predict that this situation will adversely affect 
treatment compliance. To mitigate this, they suggested that 
more health centers with available MDTs be established so 
that patients will no longer have to travel to Metro Manila 
to get treated. Additionally, health workers advocated for the 
improvement of treatment availability (i.e. MDT and drugs 
for reactions), especially in hard-to-reach areas.
Counselling and Support Groups
Health workers recommended that the NLCP 
strengthen the implementation of its guidelines and focus 
training on counseling among frontline health workers. They 
emphasized that while trainings are usually about clinical 
diagnosis and management, training on counselling skills is 
equally important since this helps keep patients in treatment, 
assuage fears related to stigma, improve the patients’ mental 
health status and improve their quality of life.7,8 
Health workers also emphasized the importance of 
support groups and how incentives administered through 
these support groups could play a role in motivating patients 
to return for treatment.
Active Case Finding and Health Education 
Health workers also recommended intensified case 
finding, especially in highly endemic areas. 
Lastly, doctors emphasized the importance of health 
education for the reduction of stigma, which is a major 
hindrance to treatment compliance. They also suggested 
educating the patients, their families, and the community. 
Organizing events such as poster-making contests for grade 
school and high school students may help raise awareness.
dISCuSSION
This study has shown that there are major variations 
in the protocols for diagnosis, patient counselling, basis 
for initiating treatment, as well as patient monitoring. The 
hospitals included in the study used different definitions of 
‘treatment completion’ and ‘treatment default’ and this could 
affect the way leprosy patients are managed.
Both the 2002 NLCP MOP and the latest report of 
the WHO Expert Committee on Leprosy do not require 
SSS and skin biopsy to be performed for diagnostic and 
monitoring purposes.6,7 However, the three hospitals require 
that these procedures be done. Health workers explained that 
SSS helps in determining prognosis and confirming diagnosis 
while skin biopsy is used in confirming leprosy when SSS 
result is negative. While the performance of more diagnostic 
tests increases certainty of diagnosis, this entails additional 
costs in terms of time, reagents and manpower. In addition to 
additional costs, the performance of skin biopsy might cause 
delays in the initiation of treatment and poorer compliance to 
doctor’s orders, especially for Hospital B patients where skin 
biopsy is done outside the hospital.
Currently, there are no local guidelines for health workers 
in the counselling of leprosy patients. The suggestions put 
forth by some participants in the results section may be 
used in formulating these guidelines on counselling and in 
training of health workers in managing leprosy patients. 
Group counselling through leprosy support groups, can help 
minimize not only financial and temporal costs but also stigma 
as patients are given opportunities to interact with others.7,9,10
There are differences in how health workers monitor 
patient compliance to treatment. One nurse reminded 
patients through SMS messaging, only to be hindered by 
inaccurate contact details provided by the patients. As a result, 
patients failed to seek treatment, or discontinued treatment 
altogether. Several leprosy experts suggested that health 
workers should strive harder to increase the public’s awareness 
and knowledge regarding the disease.7,9,11 Education of the 
family and the general public about leprosy will hopefully 
foster an atmosphere that encourages treatment compliance. 
While these efforts should continue, the importance of 
reminding patients to come back for treatment is paramount. 
Health workers dealing with leprosy patients can adopt good 
practices used in handling tuberculosis cases since both TB 
and leprosy require long periods of treatment. Regularly 
reminding patients to come for treatment appeared to have 
worked well in TB control.12
Resident physicians discussed the need for extending 
treatment on certain occasions. They extend it to a maximum 
of 36 months, far from the 12 months duration suggested 
by the WHO. Some medical personnel say that 24 months 
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of treatment is effective for patients with an initial bacterial 
index of 4+ or higher. This is recommended by the PDS and is 
supported by the Guidelines for the Control of Leprosy in the 
Northern Territory of Australia.13 These state that extending 
treatment to 24 months in patients with an initial bacterial 
index of at least 4+ or higher minimizes relapse.13-15 A doctor 
from one of the hospitals also elaborated on the presence of 
‘persisters’ as a reason for extending treatment. ‘Persisters’ have 
been defined as “permanently or partially dormant organisms 
that have the capacity to survive in the host despite adequate 
chemotherapy.”16 Its presence is thought to be a risk factor for 
relapse once activated, and a few of these ‘persisters’ have been 
documented to be resistant to dapsone and rifampicin.16,17
These findings have wide-ranging implications in terms 
of cost and duration of treatment. Extending treatment might 
decrease the risk of relapse, but this will entail more costs. 
Furthermore, while there are studies documenting relapses 
after MDT,15-18 there is no evidence in literature to support 
the belief that the 24-month duration is indeed cost-effective 
in preventing relapse among leprosy patients. As such, further 
studies are needed to establish clear-cut policies with regard 
to treatment duration. Some issues, such as the emergence 
of ‘persisters’ and drug-resistant leprosy, should be addressed 
alongside those concerning treatment duration. Policies that 
will benefit patients the most must be crafted to prevent the 
further spread of leprosy.
There were issues with the hospitals’ definitions of 
default. This means that defaulter statistics from each hospital 
may not be comparable. Thus, definitions of default, as well as 
for those patients who were placed on extended treatment, 
should be standardized as they may represent substantial 
number of patients in treatment. 
Among the various practices mentioned, none is 
considered inferior or superior to another. As such, the results 
of this study should not be utilized to incriminate hospitals 
for not observing the treatment guidelines. Rather, these 
differences in practices should be assessed through further 
research to determine which practice or combinations of 
practices, given constraints in time, manpower and resources, 




There are variations in the clinical management of 
leprosy patients between the three hospitals, and from 
Philippine NLCP MOP, and the WHO standards. These 
variations may necessitate their evaluation relative to the 




The following recommendations are made by the 
researchers to address the issues highlighted in the study.
Standardize definitions of treatment completion 
and default
The definitions of treatment completion and default 
should be standardized and used consistently in all treatment 
centers to allow accurate computation of treatment 
completion and defaulter rates as well as allow comparability 
of information. Standardizing definition of terms and patient 
management will allow more valid statistics to monitor 
progress towards disease elimination.
More in-depth training of health professionals 
which includes psychological evaluation of 
patients and counselling
Often an underrated aspect of case management of 
leprosy, counselling was deemed by the healthcare providers 
as a vital aspect in patient treatment compliance. In addition 
to establishing guidelines for counselling of leprosy patients, 
healthcare providers should also be trained in psychological 
evaluation of patients and counselling. This will help in 
assuaging patient fears related to stigma, and hopefully, in 
improving treatment compliance.
Further Research
This study highlights the need to further evaluate the 
effectiveness of current practices of healthcare providers 
relative to the current standards of leprosy patient 
management.
Technical Appendix – FGD Questionnaire
Good Morning/Afternoon/Evening Sir/Ma’am! Today 
we will talk about the reasons for treatment compliance and 
default of leprosy patients from your experience as a leprosy 
worker and about the MDT therapy. Please do answer the 
questions honestly and with the best of your abilities. We 
cannot give you full assurance that the information that you 
gave will be kept confidentiality since you are joined by others 
in this FGD. Can we begin the FGD now? 
1. Can you describe what you usually do when a suspected 
leprosy patient comes in for consultation? 
2. Can you please describe to us how a person with leprosy 
looks like?
3. What clinical or lab tests do you usually do in the hospital 
to diagnose a suspected patient?
3.1 Were there instances when the clinical or lab tests 
could not be done on the patient? Why does this 
happen?
4. What do you usually do to confirm the initial diagnosis? 
4.1 Ask for reasons why no confirmation is done if this 
is the case. What do you usually recommend your 
patients do if diagnosis cannot be confirmed?
5. What do you tell the patient after he/she is diagnosed?
5.1 Probe to determine if counseling is done. 
5.2 Find out how counseling can affect treatment 
compliance.
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6. When do you usually start MDT? 
6.1 If patients are not placed on MDT immediately, ask 
for the reasons.
6.2 If patient is referred to another facility, ask why this 
is the case. 
7. For time that you have worked with leprosy patients, 
have you encountered patients who did not finish the 
treatment prescribed (default cases)?
7.1 If yes, why do you think they defaulted? 
8. For patients who fully complied with their treatment 
regimen, what do you think are their reasons for doing so?
9. How do you do follow-up your patients?
10. In what way will disability and other complications 
influence treatment compliance? In what way can stigma 
due to the disease affect treatment compliance? 
11. What can you suggest to improve treatment compliance 
to the MDT?
Thank you for your time.
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APPENdIX
Table 1. Summary of practices of the various hospitals in terms of diagnosis, treatment initiation, counselling, patient monitoring, treatment 
completion, and default as compared to the 2002 DOH Leprosy MOP and/or the WHO Expert Committee Report.
 2002 DOH Leprosy MOP6 or the 
WHO Expert Committee Report7 Hospital A Hospital B Hospital C
Diagnosis MOP: Diagnosis of leprosy 
is based on clinical signs and 
symptoms; especially when 
there is history of contact with 
positive case.
Slit skin smear (SSS) is only 
performed when diagnosis 
is doubtful. 
Assessment of signs and 
symptoms. 
SSS and complete blood count 
(CBC) is required. 
Skin biopsy is only performed if 
SSS is negative. 
Laboratory tests relevant to 
diagnosis of leprosy is free.
Assessment of signs and 
symptoms; including 
neurologic physical exams.
Specimen collection for SSS 
and skin biopsy is required 
and is performed for free at 
the hospital. Slit skin smear 
readings are done outside 
the hospital and may not 
be free. 
Assessment of signs and 
symptoms; including 
neurologic examinations. 
SSS and skin biopsy are 
required tests; CBC, SSS, 
skin biopsy, urinalysis, and 
liver and kidney function 
tests are free, but chest 
X-ray and glucose-6-
phosphate dehydrogenase 
test (G6PD) are not. 
Treatment 
Initiation
MOP: Treatment should start as 
soon as leprosy is diagnosed in 
a patient.
Treatment started on the same 
day of diagnosis. 
Initiation of treatment is 
done on a case-to-case 
basis. G6PD test is required 
before treatment is started.
Treatment is only initiated 
if SSS or skin biopsy is 
positive. G6PD test is 
also required. 
Counselling MOP: Not discussed.
WHO Expert Committee Report:
Counselling is important in 
addressing stigma of leprosy, and 
should be started at the time 
of diagnosis. 
Counselling on what 
the disease is about, its 
manifestations, and its mode of 
transmission. Emphasis is given 
on the benefits of treatment. 
Relatives are included in 
counselling if they are present. 
Flyers and pamphlets are given. 
Group counselling through 
Hansen’s clubs. 
Counselling on what 
the disease is about, its 
manifestations, and its 
mode of transmission. 
Emphasis is given on 
avoiding stigmatizing terms 
in disclosing the diagnosis 
to the patient. Flyers 
and pamphlets are given. 
Group counselling through 
Hansen’s clubs.
Counselling on what 
the disease is about, its 
manifestations, mode of 
transmission. 
Emphasis is given on 
prognosis, consequences of 
having the disease, and the 
importance of treatment 
compliance and follow-up 




MOP: Patients may be given extra 
medicines so that they need to 
come back often if they live far 
from the hospital.
Health workers should observe 
changes to the character of the 
lesions, and development of new 
signs or symptoms. 
Use of Short Messaging Service 
(SMS) to remind patients to get 
their monthly treatment and 
check-up.
Giving more than a month’s 
treatment is allowed under 
certain circumstances.
Giving more than a month’s 
treatment is allowed under 
certain circumstances. 
Patients who experience 
lepra reactions are asked to 
return every two weeks.
Maximum of three blister 
packs are given to a patient. 
Lepra reactions, joint 
pains and new lesions are 
observed every check-up. 
Patients who experience 
lepra reactions are asked to 
return every two weeks. 
Treatment 
Completion
MOP: Treatment completion is 
defined as “having taken 12 MDT 
blister packs within 18 months”. 
Patients who have completed 
treatment is classified into two: 
“released from treatment” and 
“completed treatment”.
Treatment may be extended 
up to 18 or even 24 months 
depending on the bacterial or 
morphological index.
SSS is performed at least twice: 
at the start of treatment and 
before the patient is released 
from treatment. It may also 
be performed any time at the 
discretion of the doctor. 
Treatment may be 
extended up to 18 or even 
24 months depending 
on the bacterial or 
morphological index.
SSS and skin biopsy is 
performed at diagnosis 
and is repeated every 12 
months until the patient is 
released from treatment. 
Patients who have 
completed treatment 
is classified into two: 
“released from treatment” 
and “completed treatment”.
Treatment may be extended 
up to 36 months because 
SSS results contained viable 
bacteria even after 24 
months of treatment.
SSS is done at the start of 
treatment and every six 
months thereafter until 
completion of treatment. 
Treatment
Default
MOP: Having started treatment 
but has not collected MDT drugs 
for six consecutive months”
WHO Expert Committee Report:
An individual who fails to 
complete treatment within the 
maximum allowed time frame.
Mentioned a new report where 
two consecutive months of not 
getting treatment is already 
considered default.
There is no definition of default 
for those who extended 
treatment. 
Six months’ leeway may 
not be consecutive for a 
patient to be considered 
defaulted. This definition is 
also applied to those who 
have extended treatment. 
A patient is considered 
defaulted if they do not 
come back for three 
consecutive months. 
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